Guidelines for Conducting Stress Testing as per ICH Q1A(R2)

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stress testing of drug substances and drug products in accordance with the ICH Q1A(R2) guidelines. This SOP ensures that stress testing identifies degradation products and provides data on stability under various conditions.

2) Scope

This SOP applies to all personnel involved in the design, execution, and documentation of stress testing for drug substances and drug products intended for global markets.

3) Responsibilities

Stability Testing Team: Responsible for conducting stress testing and documenting results in compliance with ICH Q1A(R2) guidelines.

Quality Assurance (QA) Team: Responsible for reviewing and approving stress testing protocols and reports.

Regulatory Affairs Team: Responsible for ensuring that stress testing meets the regulatory expectations of target markets.

4) Procedure

4.1 Preparation for Stress Testing

4.1.1 Obtain and review the latest ICH Q1A(R2) guidelines for

“Future of Drug Stability: How Pharmaceutical Stress Testing Safeguards Against Degradation and Ensures Medication Efficacy”

4.1.2 Develop a stress testing protocol that includes study design, testing schedule, storage conditions, and testing parameters as per ICH guidelines.

4.2 Selection of Samples

4.2.1 Select representative samples of the drug substance or product for stress testing.

4.2.2 Prepare sufficient samples to cover all stress conditions to